Package Leaflet: Information for the Patient
Fluoxetine Combix 20 mg Dispersible Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Fluoxetine Combix contains the active substance fluoxetine hydrochloride, which belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs).
This medicine is indicated for the treatment of:
Adults:
Children over 8 years and adolescents:
How Fluoxetine Combix works
Everyone has a substance in their brain called serotonin. People who are depressed or have obsessive-compulsive disorder or bulimia nervosa have lower levels of serotonin than others. It is not fully understood how fluoxetine and other SSRIs work, but they may help by increasing the levels of serotonin in the brain.
Treating these conditions is important to help you improve. If left untreated, your illness may not disappear and may become more severe and more difficult to treat.
You may need to be treated for a few weeks or months to make sure you are free of symptoms.
Do not take Fluoxetine Combix
Treatment with fluoxetine may only be started at least 2 weeks after stopping treatment with an irreversible non-selective MAOI.
Do not takeany irreversible non-selective MAOI for at least 5 weeks after stopping fluoxetine medication. If you have been prescribed fluoxetine for a long period and/or at a high dose, your doctor may consider the need for a longer interval before taking an MAOI.
Warnings and precautions
Consult your doctor or pharmacist before starting to take fluoxetine if you have any of the following:
Suicidal thoughts and worsening of your depression or anxiety disorder
If you are depressed and/or have an anxiety disorder, you may sometimes have thoughts of harming or killing yourself. These may increase when you first start taking antidepressants, as all these medicines need time to start working, usually around 2 weeks, although sometimes a little longer.
You are more likely to think this way:
If you have thoughts of harming or killing yourself at any time, contact your doctor or go to hospital straight away.
You may find it helpful to tell a relative or close friendthat you are depressed or have an anxiety disorder and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Children and adolescents aged 8 to 18 years:
Patients under 18 years have an increased risk of side effects such as suicide attempts, suicidal thoughts, and hostility (predominantly aggression, confrontational behavior, and irritability) when taking this class of medicines. Fluoxetine should only be used in children and adolescents aged 8 to 18 years for the treatment of moderate to severe depressive episodes (in combination with psychological therapy), and should not be used for other indications in this age group.
In addition, there is only limited information on the long-term safety of fluoxetine in relation to growth, puberty, and cognitive, emotional, and behavioral development in this age group. Nevertheless, if you are a patient under 18 years, your doctor may prescribe fluoxetine for the treatment of moderate to severe depressive episodes, in combination with psychological therapy, when they decide that it is the best option for you. If your doctor prescribes fluoxetine to a patient under 18 years and you wish to discuss this decision, please go back to your doctor. You should inform your doctor if any of the above symptoms appear or worsen when patients under 18 years are taking fluoxetine.
Fluoxetine should not be used in the treatment of children under 8 years of age.
Sexual dysfunction
Some medicines of the same group as fluoxetine (called SSRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Other medicines and Fluoxetine Combix
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Do not take Fluoxetine Combix with:
Treatment with fluoxetine should only be started at least 2 weeks after stopping treatment with an irreversible non-selective MAOI (e.g. tranylcypromine). Do nottake any irreversible non-selective MAOI for at least 5 weeks after stopping fluoxetine medication. If you have been prescribed fluoxetine for a long period and/or at a high dose, your doctor may consider the need for a longer interval before taking an MAOI.
Fluoxetine may affect the action of other medicines (interaction):
Taking Fluoxetine Combix with food, drinks, and alcohol
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Talk to your doctor as soon as possible if you are pregnant, think you may be pregnant, or are planning to become pregnant.
In babies whose mothers took fluoxetine during the first months of pregnancy, there are studies that describe a higher risk of suffering from congenital heart defects. In the general population, about 1 in 100 babies are born with a heart defect. This probability increased to about 2 in 100 in babies whose mothers took fluoxetine.
When taken during pregnancy, particularly in the last 3 months of pregnancy, medicines like fluoxetine may increase the risk of a serious disease in babies called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and turn blue. These symptoms usually start during the first 24 hours after the baby is born. If this happens to your baby, contact your midwife and/or doctor immediately.
If you take fluoxetine in the final stages of pregnancy, there may be a higher risk of heavy vaginal bleeding soon after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking fluoxetine so they can advise you.
It is preferable not to use this treatment during pregnancy unless the potential benefit outweighs the potential risk. Therefore, you and your doctor may decide to stop taking fluoxetine gradually during pregnancy or before becoming pregnant. However, depending on your circumstances, your doctor may suggest that it is better for you to continue taking fluoxetine.
Caution should be exercised when used during pregnancy, especially during the last stage of pregnancy or just before delivery, as the following effects have been reported in newborn babies: irritability, tremors, muscle weakness, persistent crying, and difficulty sleeping or feeding.
Breastfeeding
Fluoxetine is excreted in breast milk and may cause side effects in children. You should only continue breastfeeding if it is absolutely necessary. If you continue breastfeeding, your doctor may prescribe a lower dose of fluoxetine.
Fertility
In animal studies, fluoxetine has been shown to reduce sperm quality. This may theoretically affect fertility, but it has not yet been observed to have an impact on human fertility.
Driving and using machines
During treatment with fluoxetine, you may feel drowsy or dizzy. Do not drive or operate tools or machines until you know how the treatment with fluoxetine affects you.
Fluoxetine Combix contains aspartame
This medicine contains 4 mg of aspartame in each tablet.
Aspartame is a source of phenylalanine, which may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates because the body cannot eliminate it properly.
Fluoxetine Combix contains sodium benzoate
This medicine contains 0.02 mg of sodium benzoate in each tablet.
Fluoxetine Combix contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially “sodium-free”.
Note: There are no image placeholders in the provided HTML code, so there is nothing to translate in that regard.Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Do not take more tablets than indicated by your doctor.
Swallow the tablets with half a glass of water, or dissolved in half a glass of water that you should swallow whole immediately. Do not chew the tablets.
Adults:
The recommended dose is:
Use in children and adolescents from 8 to 18 years with depression:
Treatment should be initiated and supervised by a specialist. The initial dose is 10 mg/day (administered as 2.5 ml of the fluoxetine oral solution presentation). After one or two weeks, your doctor may increase the dose to 20 mg/day. The dose should be carefully increased to ensure that you receive the lowest effective dose. Children with low weight may need lower doses. If there is a satisfactory response to treatment, your doctor should reassess the need to continue treatment after 6 months. If you have not improved within 9 weeks, treatment should be reconsidered.
Elderly patients:
Dose increases made by your doctor should be carried out more carefully, and the daily dose should not generally exceed 2 tablets (40 mg). The maximum dose is 3 tablets (60 mg) daily.
Hepatic impairment:
If you have a liver problem or are using other medication that may affect fluoxetine, your doctor will decide whether to prescribe a lower dose or instruct you on how to use fluoxetine on alternate days.
If you take more Fluoxetina Combix than you should
In case of overdose or accidental ingestion, go to the emergency department of the nearest hospital, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. If possible, bring the Fluoxetina Combix packaging with you.
The symptoms of overdose include: nausea, vomiting, seizures, heart problems (such as irregular heartbeats or cardiac arrest), lung problems, and changes in mental state ranging from excitement to coma.
If you forget to take Fluoxetina Combix
If you stop treatment with Fluoxetina Combix
You may experience the following effects (withdrawal effects) when stopping treatment with fluoxetine: dizziness, sensation of tingling similar to pinpricks or needles, sleep disorders (intense dreams, nightmares, insomnia), feeling of restlessness or agitation, unusual fatigue or weakness, anxiety, nausea and/or vomiting (feeling sick or being sick), tremors (instability), and headache.
Most people find that the symptoms that occur when stopping treatment with fluoxetine are moderate and disappear within a few weeks. If you experience these symptoms when stopping your treatment, consult your doctor.
When stopping treatment with fluoxetine, your doctor will help you gradually reduce the dose over one to two weeks - this will help reduce the possibility of withdrawal effects.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can produce adverse effects, although not all people experience them.
The most frequent adverse effects (very frequent adverse effects that may affect more than 1 in 10 people) are insomnia, headache, diarrhea, discomfort (nausea), and fatigue.
Some patients have experienced:
If you experience any of the above adverse effects, inform your doctor immediately.
The following adverse effects have also been reported in patients taking fluoxetine:
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from available data)
Bone fractures:In patients taking this type of medication, an increased risk of bone fractures has been observed.
Most of these adverse effects tend to disappear with continued treatment.
In children and adolescents (8 to 18 years) –In addition to the possible adverse effects mentioned above, fluoxetine may decrease growth or delay sexual maturation. Suicidal behavior (suicide attempts and suicidal thoughts), hostility, mania, and nasal bleeding have also been frequently reported in children.
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Fluoxetina Combix
Appearance of the product and package contents
Fluoxetina Combix 20 mg are dispersible, uncoated tablets, white or almost white, oval-shaped, biconvex, and scored on both sides. The tablet can be divided into equal doses.
The tablets are presented in blisters, available in packages of 14, 28, and 60 tablets.
Marketing authorization holder
Laboratorios Combix, S.L.U.
C/ Badajoz 2, Edificio 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Manufacturer
Zydus France
ZAC Les Hautes Patures
Parc d'activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
O
Centre Spécialités Pharmaceutiques
ZAC des Suzots
35 rue de la Chapelle
63450 Saint Amant Tallende
France
O
Netpharmalab Consulting Services
Carretera de Fuencarral 22
28108 Alcobendas, Madrid
Spain
O
Pharmex Advanced Laboratories S.L.
Ctra. A-431 Km. 19
14720 Almodóvar del Río (Córdoba)
Spain
O
Flavine Pharma France
3 Voie d’Allemagne
13127 Vitrolles
France
Date of the last revision of this prospectus: December 2022
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).